HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 22 June 2016

May's CEAs.....

The CEA Registry Blog has in the past published a list of recent CEAs, from which we have flagged up studies of interest to HEDS. They have stopped publishing this, which is a shame.  So, we're doing it instead!

In the right-hand column is a CEA Archive, which includes our CEA search results by month.  Below are those in our areas of interest.

  • Zur RM, Zaric GS. A microsimulation cost-utility analysis of alcohol screening and brief intervention to reduce heavy alcohol consumption in Canada. Addiction (Abingdon, England). 2016;111(5):817-31.
  • Wallbillich JJ, Forde B, Havrilesky LJ, Cohn DE. A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy. Gynecologic oncology. 2016.
  • Garcia A, Ortiz de Lejarazu R, Reina J, Callejo D, Cuervo J, Morano R. Cost-Effectiveness Analysis Of Quadrivalent Influenza Vaccine In Spain. Human vaccines & immunotherapeutics. 2016:0.
  • Gasparini R, Landa P, Amicizia D, Icardi G, Ricciardi W, de Waure C, et al. Vaccinating Italian infants with a new multicomponent vaccine (Bexsero(R)) against meningococcal B disease: A cost-effectiveness analysis. Human vaccines & immunotherapeutics. 2016:1-14.
  • Russell LB, Sinha A. Strengthening Cost-Effectiveness Analysis for Public Health Policy. American journal of preventive medicine. 2016;50(5 Suppl 1):S6-s12.